Testosterone in women is medically useful only in specific, well-defined situations, such as hypoactive sexual desire disorder (HSDD) after menopause, after excluding other causes. However, regulatory approval in Europe is very limited; no testosterone product is explicitly approved for women in Germany. Clinical trials show moderate efficacy for improving libido and well-being, but long-term safety data are insufficient – risks include cardiovascular events, acne, hair loss, and voice changes. MyBody-X home tests can measure testosterone levels, but a single snapshot is unreliable due to strong cyclical variation. Interpretation requires an endocrinologist. Without a medical indication and monitoring, self-administration of testosterone is not recommended. Evidence: moderate for HSDD in postmenopausal women; no approval for general anti-aging or wellness use. Caveat: off-label use is common but lacks robust evidence.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4db17c21cbed0c9ff696e258